NCT01251861 2026-03-18
Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
411 trialsNCT02893917 2026-03-18
Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT03663218 2026-03-18
PREPARE SBRT
Weill Medical College of Cornell University
Phase NA Active not recruiting
NCT04514484 2026-03-18
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT05343936 2026-03-18
Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population
Hospital Moinhos de Vento
Active not recruiting
NCT05828082 2026-03-18
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06408597 2026-03-18
Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy
Cairo University
Phase NA Active not recruiting
NCT03445559 2026-03-17
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
VA Office of Research and Development
Phase NA Active not recruiting
NCT05245006 2026-03-17
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer
University of California, San Francisco
Phase 1 Active not recruiting
NCT07038369 2026-03-17
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Phase 1 Active not recruiting
NCT07477626 2026-03-17
RADVAN
Sun Yat-sen University
Phase 3 Active not recruiting
NCT04108208 2026-03-16
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)
Janssen Research & Development, LLC
Phase 4 Active not recruiting
NCT04190446 2026-03-16
A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer
Mayo Clinic
Phase 2 Active not recruiting
NCT05114746 2026-03-16
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan
Novartis
Phase 2 Active not recruiting
NCT03523442 2026-03-13
A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT04557059 2026-03-13
PRIMORDIUM
Janssen Pharmaceutica N.V., Belgium
Phase 3 Active not recruiting
NCT04577833 2026-03-13
A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT04624256 2026-03-13
GARUDA
Jonsson Comprehensive Cancer Center
Phase NA Active not recruiting
NCT04644770 2026-03-13
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT04662580 2026-03-13
ARX517
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT05022849 2026-03-13
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT03419234 2026-03-12
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
NCT04905069 2026-03-12
SABRE
Boston Scientific Corporation
Phase NA Active not recruiting
NCT05918263 2026-03-12
Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial
Dana-Farber Cancer Institute
Phase NA Active not recruiting
NCT05960578 2026-03-12
Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study
University of Washington
Phase 2 Active not recruiting
NCT06451614 2026-03-12
HYDROSPACE
Boston Scientific Corporation
Phase NA Active not recruiting
NCT06561230 2026-03-12
Leveraging EA8191 to Assess AI-Augmented EHR Abstraction
University of Pennsylvania
Active not recruiting
NCT04720157 2026-03-11
PSMAddition
Novartis
Phase 3 Active not recruiting
NCT04821622 2026-03-11
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Pfizer
Phase 3 Active not recruiting
NCT04845503 2026-03-10
SMILE
University Hospital Heidelberg
Phase NA Active not recruiting
NCT07462403 2026-03-10
A mLifestyle Intervention for Men on Androgen Deprivation Therapy for PCa
Thomas Jefferson University
Phase NA Active not recruiting
NCT00525720 2026-03-09
Brachytherapy for Prostatic Carcinoma Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT00578240 2026-03-09
Molecular Studies and Clinical Correlations in Human Prostatic Disease
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT02905318 2026-03-09
Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Canadian Cancer Trials Group
Phase 2 Active not recruiting
NCT03561220 2026-03-09
COMPPARE
University of Florida
Phase NA Active not recruiting
NCT03778112 2026-03-09
MRI Guided SBRT for Localized Prostate Cancer
Rush University Medical Center
Phase NA Active not recruiting
NCT03808077 2026-03-09
The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT06463457 2026-03-09
Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT00352924 2026-03-06
Agriculture Health Study
National Institutes of Health Clinical Center (CC)
Active not recruiting
NCT02703623 2026-03-06
Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04541030 2026-03-06
Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies
National Institutes of Health Clinical Center (CC)
Active not recruiting
NCT04748042 2026-03-06
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
University of Michigan Rogel Cancer Center
Phase 2 Active not recruiting
NCT06104449 2026-03-06
MK-5684-005
Merck Sharp & Dohme LLC
Phase 1 Active not recruiting
NCT07455097 2026-03-06
COMBINE-P
Heinrich-Heine University, Duesseldorf
Active not recruiting
NCT03085043 2026-03-05
Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT05331638 2026-03-05
PCGA
University of Oklahoma
Phase NA Active not recruiting
NCT05364229 2026-03-05
MRL-Boost PC
University Health Network, Toronto
Phase NA Active not recruiting
NCT06066437 2026-03-05
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT03674814 2026-03-04
Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer
University of Chicago
Phase 1 Active not recruiting
NCT05946993 2026-03-04
LIAM Mc
University College Cork
Phase NA Active not recruiting